12 - Disorders of White Blood Cells: Number and Function Flashcards

1
Q

HEMATOPOESIS

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

LEUKOCYTES

A
  • In unstained blood smear, leukocytes are colorless; “Leuko” meaning white
  • From bone marrow (except T-lymphocytes) → peripheral blood → tissues
  • Leukopoiesis generates 1-5 x 1011 cells/day
  • Protect host against infections/toxins/pathogens:
    *** Granulocyte/neutrophils – Phagocytosis (innate immunity)
  • Basophils – Hypersensitivity reactions; release histamine
  • Eosinophils – Allergic reactions, chronic inflammation, parasites
  • Monocytes – Phagocytosis(innate)/APC(adaptive immunity)
  • Lymphocytes (B and T cells) – Adaptive immunity**
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

GRANULOCYTE KINETICS/DISTRIBUTION

A
  • Bone Marrow
    ▪ Mitotic/proliferating pool
    ▪ Myeloblasts, promyelocytes, myelocytes
    ▪ 3-6 days
    ▪ Maturation/storage pool
    ▪ Metamyelocytes, bands, segmented neutrophils
    ▪ 5-7 days → ~2 days in infection
  • Peripheral Circulation

▪ Marginating pool (along the vessels)
▪ Circulating pool (freely circulating)
▪ 7-8 hours
* Tissue-Phase
▪ 1-2 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

White Blood Cell Disorders

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

LEUKOCYTOSIS

Quantitative WBC disorder

A

❑ WBC >11,000/microL or 2 SD above the mean in
adults
❑ Terminology:
* Left Shift: significant increase in % of bands in
peripheral blood along with some
metamyelocytes and myelocytes
* Leukemoid reaction: when WBC>50,000 and
more significant increase in earlier precursors
such as metamyelocytes and myelocytes and
sometimes promyelocytes
▪ Infections

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

NEUTROPHILIA ETIOLOGY

Quantitative WBC disorder

A

❑ ANC >7000-7500/ml
❑ Primary
* Myeloproliferative disorders (CML, ET, PV)
* Leukocyte adhesion factor deficiency
❑ Secondary
* INFECTION
* Inflammation/tissue necrosis/burns
* Malignancy
* Stress (physical/emotional stress, vigorous exercise, heat stroke)
* Cigarette smoking
* Drugs (Glucocorticoids, lithium, G/M-CSF)
* Asplenia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

monocytosis (AMC>800) - LEUKOCYTOSIS

Quantitative WBC disorder

A
  • Acute bacterial infection
  • TB, endocarditis, syphilis
  • Sarcoidosis
  • AML, ALL
  • Chronic myelomonocytic
    leukemia (CMML) –
    MDS/MPD
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Basophilia (ABC>200) - LEUKOCYTOSIS

Quantitative WBC disorder

A
  • Infections
  • CML
  • Hodgkins Lymphoma
  • Type I hypersensitivity
    reactions
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Lymphocytosis (ALC >5000) - LEUKOCYTOSIS

Quantitative WBC disorder

A
  • Infections
    -Viral/bacterial/parasitic/
    protozoal
  • Drug hypersensitivity
  • Stress
  • LGL, CLL, ALL
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Eosinophilia (AEC>500) - Leukocytosis

Quantitative WBC disorder

A
  • Allergic/atopy
  • Drugs (PCNs, NSAIDs, ranitidine,
    ASA, DRESS)
  • Parasitic/helminths
  • Hypereosinophilic syndrome (HES)
  • Hodgkins Lymphoma
  • Organ-specific
  • Adrenal insufficiency
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

LEUKOPENIAS

Quantitative WBC disorder

A

❑Lymphopenia
* Sepsis/infections
* Postoperative state
* Glucocorticoids
* Chemotherapy (Rituximab,
ATG)
* Radiation
* Autoimmune disorders
* Lymphomas

❑Monocytopenia
* Sepsis
* Chemotherapy
* Aplastic anemia
* MonoMAC syndrome
* GATA2 deficiency
* Late child/new adult
onset

❑Low eosinophils/basophils
* Drugs/Chemotherapy
* Not usually clinically significant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

NEUTROPENIA

Quantitative WBC disorder

A

❑ ANC <1500/microL
* 1500-1000: mild
* 1000-500: moderate
* <500: severe or agranulocytosis

❑ Risk of infection:
* Proportional to ANC level

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

NEUTROPENIA ETIOLOGY

Quantitative WBC disorder

A
  • DANC (Duffy-null Associated Neutrophil Count) –
    previously called benign ethnic
    neutropenia/constitutional neutropenia
  • Nutritional deficiencies
  • Medications
  • Severe infections
  • Rheumatologic/autoimmune disorders; SLE, RA
  • Congenital disorders
  • Bone marrow disorders; MDS
  • Hypersplenism
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

NEUTROPENIA MECHANISMS

Quantitative WBC disorder

A
  • Decreased production
  • Increased utilization
  • Increased destruction
  • Shift to marginating pool
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

APPROACH TO NEUTROPENIA Diagnosis

Quantitative WBC disorder

A

❑ History is key !!!
* Recurrent infections
* Family history
* Congenital neutropenia:
▪ Shwachman-Diamond Syndrome
▪ WHIM syndrome
▪ Cyclic neutropenia
▪ Severe congenital neutropenia (CSF3R gene)
▪ Kostmann Syndrome

  • Alcohol
  • Nutritional deficiencies (B12, folate, copper)
  • Medication/drug list
  • Autoimmune process
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

DRUG-INDUCED NEUTROPENIA - mechanism

Quantitative WBC disorder

A
  • Onset 7-21 days after starting medication
  • Effects can last 1-3 weeks
  • Mechanisms: decreased production; increased destruction
  • It is a clinical diagnosis
  • Bone marrow
    ▪ Absent precursors
    ▪ Maturation arrest
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

DRUG-INDUCED NEUTROPENIA - causes

Quantitative WBC disorder

A

▪ H2 antagonists
▪ Anti-thyroid (Propylthyiouracil, methimazole)
▪ NSAIDs, sulfasalzine
▪ Anti-seizures (carbamazepine, phenytoin)
▪ Antibiotics/antifungals
▪ Antiarrhythmic agents
▪ Isotretinoin
▪ Diuretics
▪ Cytotoxic chemotherapies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

CYCLIC NEUTROPENIA

Quantitative WBC disorder

A
  • Autosomal dominant
  • Elastase gene (ELANE, ELA2)
  • Recurring neutropenia every 21 days
  • Onset first few years of life
  • Symptoms:
    ▪ Fevers
    ▪ Malaise
    ▪ Recurrent infections (clostridium septicum)
    ▪ Apthous ulcers
    ▪ Gingival inflammation

Treatment:
▪ Neupogen (G-CSF) to keep ANC
>1000
▪ Supportive care

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

DANC – Duffy Null associated neutrophil count

Quantitative WBC disorder

A

❑ Pathogenesis:
* Normal neutrophil production, but issue is
redistribution of circulating to marginating
pools or decrease granulocyte reserves
* Polymorphism in the ACKR1 gene that
encodes Duffy antigen receptor chemokine
(DARC)
* Patients are negative for Duffy (Fy) Ag in their
RBC
* Approx 2 in 3 people in US of African or
middle eastern genetic ancestry have Duffy
null phenotype

❑ Clinical manifestations
* No increased risk of infection

❑ Diagnosis
* Isolated decrease in PMN
* Persistent over time
* No history of unusual or severe infections
* Family history helpful but not essential

❑ Treatment
* No therapy needed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

IMMUNE NEUTROPENIA

Quantitative WBC disorder

A
  • Antibodies against antigens on neutrophils
  • Alloimmune neonatal neutropenia
  • Maternal Abs against Fetal Ag on neutrophils
    (paternal origin)
  • Autoimmune neutropenia
  • Idiopathic
  • Secondary
  • SLE, RA
21
Q

FELTY SYNDROME

Quantitative WBC disorder

A
  • Triad
  • Rheumatoid arthritis
  • Splenomegaly
  • Neutropenia
  • Recurrent infections
  • Portal Hypertension
  • Pathogenesis
  • Anti-neutrophil antibodies destroy coated
    neutrophils
22
Q

LARGE GRANULAR LYMPHOCYTIC LEUKEMIA (LGL)

Quantitative WBC disorder

A

❑Clonal proliferation of large granular lymphocytes
* T-cells
* Natural killer (NK) cells

❑Clinical manifestations
* Neutropenia
* Recurrent infection
* Splenomegaly
* 25 – 50% have rheumatoid arthritis
* Pulmonary hypertension

❑ Diagnosis
* LGLs in peripheral blood and/or bone marrow
* Flow cytometry
* T-cell gene rearrangement (TCR)
* Negative in NK cell LGL, but positive in T-cell LGL

23
Q

NEUTROPHIL STRUCTURE

A

❑Membrane receptors

❑Granules
* Primary (azurophilic)
* MPO, defensins, Cathepsin
* Secondary (specific)
* Lactoferrin, Collagenase, Heparinase

24
Q

GRANULOCYTE DEVELOPMENT

A
25
Q

NEUTROPHIL FUNCTION

A
26
Q

DEFECTS IN NEUTROPHIL FUNCTION

A
27
Q

neutrophil DEGRANULATION AND KILLING

A

❑Oxygen Dependent
* Mediators
▪ Oxygen free radicals
▪ Halides
* NADPH oxidase
▪ Respiratory burst

❑ Oxygen Independent
* Lysozyme
* Hydrolases
* Anionic protein
* Lactoferrin
* Collagenase
* Defensins

28
Q

PHAGOCYTE OXIDASE FORMATION

A
29
Q

DEFECTS IN NEUTROPHIL FUNCTION

A
30
Q

LAD - Leukocyte adhesion defects

A
31
Q

LEUKOCYTE ADHESION DEFICIENCY

TYPE I

A

❑ Very rare (~75 reported cases)
❑ Autosomal recessive
* Heterogeneous defects 21q22.3
* Abnormal CD18
* Abnormal CD11/CD18 integrin function
▪ Absent, decreased, dysfunction
▪ Impaired CD11/CD18-ICAM interaction
▪ Impaired firm adhesion

32
Q

LEUKOCYTE ADHESION DEFICIENCY TYPE I - Clinical features

A

❑ Clinical features
* Recurrent, chronic or gangrene infections
▪ Soft tissue, gums (periodontitis)
* No pus formation
* Delayed umbilical cord separation
* Delayed wound healing

33
Q

LEUKOCYTE ADHESION DEFICIENCY TYPE I - Laboratory features and therapies

A

❑ Laboratory features
* Neutrophilia
▪ baseline 15 - 60,000/ul
▪ infection > 100,000/ul
* BM myeloid hyperplasia
* Rebuck skin window test→ rare PMN
* Flow cytometry abnormal CD18 expression

❑ Therapy
* Prophylactic antibiotics
* Allogeneic SCT for severe disease

34
Q

LEUKOCYTE ADHESION DEFICIENCY TYPE 2

A

❑ Deficient sLex
* Impaired binding to E-selection
* Impaired rolling
❑ Autosomal recessive
* Consanguineous parents
* Bombay phenotype (hh) – No H antigen to produce A, B
antigens on RBCs
* Short stature
* Cognitive deficits

35
Q

Leukocyte adhesion deficiencies - appearance

A
36
Q

CHEDIAK-HIGASHI SYNDROME

A

❑ Rare autosomal recessive disorder
❑ Generalized defect of protein trafficking and granule
morphogenesis
* Lysosomal granules
❑ Chromosome 1q42-q44
* CHS1 (LYST) gene mutated

37
Q

CHEDIAK-HIGASHI SYNDROME - CLINICAL FEATURES

A
  • Oculocutaneous albinism
  • Sable hair
  • Sun sensitivity
  • Photophobia
  • Neuropathy
  • Recurrent pyogenic infections
38
Q

CHEDIAK-HIGASHI SYNDROME - Diagnosis and treatment

A

❑ Large inclusions in all nucleated cell lines
❑ Accentuated by peroxidase stain

TREATMENT:
❑ Supportive care
❑ Prophylactic antibiotics
❑ Some data on vitamin C

39
Q

CHRONIC GRANULOMATOUS DISEASE

A

❑ Incidence 1/200,000 - 1/1,000,000
❑ Male:Female 6:1
* X-linked
* Autosomal recessive

Pathogenesis:
* Decreased NADPH oxidase activity
* Impaired respiratory burst
* Decreased H2O2 generation
* Impaired killing of catalase positive organisms

2H2O2 ——Catalase——-> 2H2O + O2

40
Q

Chronic granulomatous disease infections

A

❑ Catalase positive organisms
▪ Staph
▪ Klebsiella
▪ Serratia
▪ E. coli
▪ Pseudomonas
▪ Salmonella
▪ Enteric bacteria
▪ Aspergillus
▪ Candida
▪ Nocardia
▪ Mycobacterium

41
Q

Chronic granulomatous disease - Clinical features

A

*Lymphadenopathy
*Hepatosplenomegaly
*Oral infections
*Chronic diarrhea
*Stomatitis
*Restrictive lung disease
*Hydronephrosis
*Anemia chronic disease
*Abscess

42
Q

Chronic granulomatous disease diagnosis and treatment

A

❑ Impaired nitroblue tetrazolium (NBT) reduction
❑ Decreased superoxide or H2O2 generation

Treatment:
* Antibiotics (prophylactic +/- therapeutic)
* Anti-Inflammatory based treatments
* Allogenic stem cell transplant (ASCT)
* Gene therapy

43
Q

MYELOPEROXIDASE DEFICIENCY

A
  • Most common phagocytic disorder (1:4000)
  • Autosomal recessive (MPO gene)
  • Most patients asymptomatic; some have mucocutaneous
    infections such as thrush (Candida)
44
Q
A

C. Recombinant granulocyte colony-stimulating factor (e.g. Neupogen) support

45
Q
A

The likely diagnosis in this case is B. Benign ethnic neutropenia. Benign ethnic neutropenia is a condition that can be seen more commonly in individuals of African descent. It is characterized by a persistent mild to moderate decrease in neutrophil count without associated clinical symptoms or increased susceptibility to infections. In this case, the patient’s history of neutropenia for at least 8 years, absence of recurrent infections, and normal physical examination support the diagnosis of benign ethnic neutropenia.

46
Q
A

The compartment of granulocyte production that is not correct is:
A. Marginating pool in peripheral blood

The correct statement is that the marginating pool refers to the neutrophils that are temporarily adherent to the vascular endothelium but not actively participating in granulopoiesis. The main compartments involved in granulocyte production include the mitotic pool in the bone marrow, maturation pool in the bone marrow, storage pool in peripheral blood, and tissue-phase where neutrophils migrate to tissues in response to inflammation or infection.

47
Q
A

D. Chediak-Higashi syndrome

Chediak-Higashi syndrome is a rare autosomal recessive disorder characterized by recurrent bacterial infections, oculocutaneous albinism, and a bleeding diathesis. The peripheral blood smear often shows giant granules in leukocytes, which is indicative of this syndrome. Additionally, the history of recurrent infections, albinism, and nystagmus in this patient and his mother is consistent with Chediak-Higashi syndrome.

48
Q
A

A. Nitro Blue-Tetrazolium (NBT) test

The NBT test is commonly used to diagnose CGD. In this test, neutrophils are exposed to a substance (NBT) that they should be able to convert into a visible blue form. However, in individuals with CGD, the neutrophils are unable to produce this color change due to a defect in their ability to generate reactive oxygen species. This test helps in identifying the impaired function of phagocytes, which is characteristic of CGD.

49
Q
A

The defect in Chronic Granulomatous Disease (CGD) is:

D. NADPH oxidase activity

In CGD, there is a defect in the NADPH oxidase enzyme, which is responsible for generating reactive oxygen species (ROS) in phagocytes. This impaired function of NADPH oxidase results in the inability of neutrophils and other phagocytes to effectively kill certain bacteria and fungi.